Dynamic change in Epstein-Barr virus DNA predicts prognosis in early stage natural killer/T-cell lymphoma with pegaspargase-based treatment: long-term follow-up and biomarker analysis from the NHL-004 multicenter randomized study.
Zhong H, Cheng S, Xiong J, Chen J, Mu R, Yang H, Yi H, Song Q, Zhang H, Hu Y, Cui G, Wei J, Zhang X, Xu B, Qian W, Huang X, Hou M, Yan F, Wang X, Song Y, Liu Y, Ma X, Hu J, Li F, Wu C, Chen J, Yu L, Bai O, Xu J, Zhu Z, Liu L, Zhou X, Huang L, Tong Y, Niu T, Wu D, Jiang X, Wang C, Ouyang B, Cai G, Li B, Liu J, Li Z, Xiao R, Wang L, Jiang Y, Liu Y, Zheng X, Xu P, Wang L, Chen S, Zhao WL.
Zhong H, et al. Among authors: li z.
Haematologica. 2025 Nov 1;110(11):2714-2725. doi: 10.3324/haematol.2025.287513. Epub 2025 Apr 10.
Haematologica. 2025.
PMID: 40207715
Free PMC article.
Clinical Trial.